◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
誉衡药业 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 2.4B 2.6B 3.1B 3.1B 3.1B
Revenue Growth % -7.0% -15.5% -1.2% 2.9% --
Total Revenue 2.4B 2.6B 3.1B 3.1B 3.1B
Cost Of Revenue 1.1B 1.1B 1.3B 830.0M 793.0M
+Gross Profit 1.3B 1.5B 1.8B 2.3B 2.3B
Gross Margin % 53.5% 58.4% 56.9% 73.6% 74.0%
Total Operating Cost 2.2B 2.5B 3.1B 3.1B 3.4B
Selling Expenses 793.0M 1.1B 1.3B 1.8B 1.8B
Admin Expenses 167.0M 175.0M 213.0M 241.0M 353.0M
Rd Expenses 90.8M 85.4M 101.0M 97.7M 125.0M
Finance Expenses -1.1M 31.3M 46.7M 71.3M 87.6M
+Operating Income 285.0M 175.0M -270.0M 95.9M 579.0M
Operating Margin % 11.7% 6.7% -8.7% 3.0% 19.0%
Non Operating Income 1.2M 2.7M 1.7M 521,900 3.0M
Non Operating Expenses 2.4M 929,300 1.3M 10.4M 17.0M
Investment Income 5.3M -23.4M -245.0M -27.7M 798.0M
Fair Value Change Income -14.0M -17.9M -24.8M 18.4M 16.7M
Asset Disposal Income 3.4M 2.8M 3.8M 4.7M -617,400
Asset Impairment Loss 4.9M 3.3M 102.0M 3.3M 124.0M
Other Income 71.7M 78.1M 27.5M 57.2M 62.6M
Income Before Tax 284.0M 177.0M -270.0M 86.0M 565.0M
Income Tax 41.2M 48.1M 19.8M 32.1M 156.0M
+Net Income 243.0M 129.0M -290.0M 53.8M 409.0M
Net Margin % 10.0% 4.9% -9.3% 1.7% 13.4%
Net Income Attributable 233.0M 120.0M -291.0M 45.0M 400.0M
Minority Interest 9.8M 8.4M 1.8M 8.8M 8.6M
Eps Basic 0.11 0.05 -0.13 0.02 0.18
Eps Diluted 0.10 0.05 -0.13 0.02 0.18
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 482.0M 711.0M 1.2B 1.5B 895.0M
Trading Financial Assets 30.0M -- 50.6M -- --
Accounts Receivable 125.0M 205.0M 229.0M 225.0M 332.0M
Notes Receivable 1.2M 729,300 954,600 3.5M --
Notes And Accounts Receivable 126.0M 206.0M 230.0M 229.0M 332.0M
Prepayments 14.3M 10.2M 29.5M 23.9M 27.8M
Inventory 189.0M 191.0M 214.0M 352.0M 371.0M
Total Current Assets 877.0M 1.2B 1.8B 2.2B 1.8B
Long Term Equity Investment 68.3M 68.5M 282.0M 295.0M 356.0M
Fixed Assets -- 1.1B 1.1B 1.2B 1.3B
Fixed Assets Total 1.0B 1.1B 1.1B 1.2B 1.3B
Construction In Progress -- 3.0M 12.9M 1.8M 6.0M
Construction In Progress Total 1.9M 3.0M 12.9M 1.8M 6.0M
Intangible Assets 167.0M 191.0M 221.0M 290.0M 350.0M
Long Term Deferred Expenses -- -- 5.2M 10.8M 24.1M
Total Non Current Assets 1.9B 2.0B 2.3B 2.5B 2.7B
Total Assets 2.8B 3.2B 4.1B 4.7B 4.5B
Short Term Borrowings -- 676.0M 1.5B 1.6B 1.4B
Accounts Payable 60.4M 69.9M 75.5M 170.0M 221.0M
Advance Receipts -- -- -- -- 9.7M
Contract Liabilities 44.2M 50.0M 83.2M 87.0M 49.3M
Total Current Liabilities 823.0M 1.4B 2.3B 2.7B 2.5B
Long Term Borrowings -- -- -- -- --
Total Non Current Liabilities 29.2M 31.1M 34.3M 37.9M 42.9M
Total Liabilities 852.0M 1.4B 2.4B 2.7B 2.6B
Paid In Capital 2.3B 2.2B 2.2B 2.2B 2.2B
Capital Reserve 457.0M 380.0M 471.0M 448.0M 445.0M
Surplus Reserve -- -- -- 343.0M 343.0M
Retained Earnings -681.0M -914.0M -1.0B -1.1B -874.0M
Minority Equity 22.2M 48.5M 72.3M 84.7M 86.7M
Equity Attributable 2.0B 1.7B 1.6B 1.9B 1.8B
Total Equity 2.0B 1.7B 1.7B 2.0B 1.9B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 2.8B 2.9B 3.4B 3.6B 3.4B
Tax Refunds Received -- -- -- -- 1.3M
Total Operating Cash Inflow 2.9B 3.1B 3.6B 3.7B 3.7B
Cash Paid For Goods 416.0M 415.0M 570.0M 679.0M 614.0M
Cash Paid To Employees 369.0M 432.0M 528.0M 592.0M 869.0M
Taxes Paid 255.0M 266.0M 288.0M 281.0M 313.0M
Total Operating Cash Outflow 2.5B 2.8B 3.3B 3.5B 3.6B
Operating Cash Flow 411.0M 274.0M 262.0M 274.0M 12.8M
Total Investing Cash Inflow 36.7M 529.0M 504.0M 1.6B 2.4B
Total Investing Cash Outflow 95.6M 435.0M 728.0M 1.6B 1.3B
Investing Cash Flow -58.9M 94.4M -224.0M 81.3M 1.0B
Cash From Borrowings 115.0M 1.1B 1.6B 1.9B 1.7B
Dividends And Interest Paid 9.4M 43.8M 76.1M 75.4M 142.0M
Debt Repayments 790.0M 1.9B 1.7B 1.7B 3.0B
Total Financing Cash Inflow 218.0M 1.1B 1.7B 2.1B 1.9B
Total Financing Cash Outflow 801.0M 2.0B 1.9B 1.8B 3.6B
Financing Cash Flow -583.0M -889.0M -213.0M 362.0M -1.7B
Net Change In Cash -230.0M -520.0M -163.0M 715.0M -639.0M
Ending Cash Balance 481.0M 711.0M 1.2B 1.4B 678.0M
Capex 62.9M 29.6M 33.0M 34.5M 43.7M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...